Notes
Slide Show
Outline
1
Diseases of the Stomach
2
Equine Gastric Ulcer Syndrome
3
Prevalence of Equine
Gastric Ulcer Syndrome (EGUS)
  • 60% to 93% in performance horses
  • 25% to 50% in foals
4
EGUS: Public Perceptions
  • Telephone Survey conducted in 2003, of 300 performance horse owners
5
Impact of
EGUS on Adult Horses
  • Results in poor body condition
  • Can disrupt training
  • Can impair performance
  • Can cause colic
  • Can have severe complications
    • duodenal strictures
6
Impact of EGUS on Foals
  • Gastric outflow
    obstruction
  • Esophagitis
  • Chronic ulceration
  • Perforation (rupture)
    & peritonitis
7
The Stomach of the Horse
8
Compartments of the Equine Stomach
9
Cause of EGUS: Aggressive Factors
Overpowering Defensive Factors
  • Gastric lining damage occurs when:
  • Aggressive (acid, pepsin, bile,
    organic acids) factors overpower
  • Defenses (bicarbonate, mucus)
    of gastric mucosa
  • Squamous mucosa lining lacks these defenses
10
Risk Factors for EGUS: Training/Racing
  • Intensive exercise
    • Reduced blood flow to the stomach lining?
    • Increased gastric acidity?
    • Altered eating behavior?
11
Acids forced into the proximal stomach
12
Risk Factors for EGUS: Feeding
  • Feeding management
    • Low prevalence of ulcers in horses at pasture
13
Risk Factors for EGUS: Feeding
    • Decreased acid when roughage available


    • Increased serum gastrin when fed
      concentrates (grains & sweet feeds)


    • Intermittent feed deprivation =
      gastric ulcers


    • Stall confinement = gastric ulcers


    • Feeding alfalfa hay may help!
14
Gastric Acidity Profile: No Feed
15
Gastric Acidity Profile: Grass Hay
16
Hydrochloric Acid-Induced Ulcers
  • Gastric acidity is high in empty stomach
  • Intermittent feed deprivation
    • Lesions form in squamous mucosa
    • No lesions form in glandular mucosa
    • Lesions prevented by ranitidine (Zantac®)
17
Risk Factors for EGUS: Stress
  • Physical stress
    • Illness
    • Painful musculoskeletal disorder

  • Behavioral stress
    • Stall confinement
    • Transport
    • Unfamiliar environment,
      social regrouping
18
Risk Factors for EGUS:
Non-Steroidal Anti-Inflammatory Drugs
  • Phenylbutazone & Flunixin Meglumine
    and other NSAIDs
  • Associated with ulcers throughout the intestinal tract (Cecum & Colon)
  • Inhibit prostaglandins, interrupting
    mucosal blood flow
    and mucus
  • Local toxicity
19
Clinical Signs of
EGUS in Adult Horses
  • Poor appetite
  • Poor body condition
  • Attitude changes
  • Decrease in performance
  • Mild to moderate colic
20
Clinical Signs of EGUS in Foals
  • Poor appetite or intermittent nursing
  • Colic
  • Poor body condition
  • Frequently lies on back
  • Bruxism (grinding of teeth)
  • Excessive salivation (Ptylism)
  • Diarrhea
21
 
22
How can you tell that a Horse
has EGUS?  (Diagnosis)
  • Clinical signs are suggestive of, but not specific for, EGUS
  • Lab: Mild anemia
  • Response to treatment can be useful
  • Gastric endoscopy is only definitive diagnostic tool
23
Endoscopic Evaluation
  • Endoscope quality
    & dimensions
    • 9 ft long
    • Small diameter
  • Patient preparation
  • Experience
24
Endoscopic Evaluation: Adults
25
Endoscopic Evaluation: Adults (cont’d)
26
Endoscopic Evaluation: Foals
27
Endoscopic Evaluation:  Foals (cont’d)
28
Treatment of EGUS
  • Eliminate clinical signs
  • Promote healing
  • Prevent complications
  • Prevent recurrences
29
There Are Two Compatible Approaches to Treatment
  • Management modifications
  • Medical therapy-approaches that have been used
    • Control gastric acid
    • Mucosal protectants
30
Traditional Management Modifications
  • Reduce level of training
31
Traditional Management Modifications
  • Diet modifications
    • Limit periods of fasting
    • Increase roughage
      • pasture turnout (green grass)
      • free choice hay
      • Alfalfa hay-dietary antacid
    • Reduce grain/concentrates
32
Dietary Management
  • Fresh Rice Bran and Rice Bran Oil
    • Contains surface active phospholipids and cytoprotective factors that maintain health of the stomach lining
    • Rancidity can be a problem
      • Produces ketoaldehydes which are ulcerogenic
    • Steam pasteurization can help decrease potential for rancidity
    • Storage in refrigerator
33
Management Modifications
  • Limit stressful events
  • Long-term stall confinement
  • Trailering
  • Overcrowding
34
Organic Acids (VFAs or SCFAs)
High Concentrate Diets
  • Acetic, Butyric, Propionic, and Valeric Acids
  • Byproducts of carbohydrate fermentation in
    the stomach
  • Synergistic with HCl
  • May lead to non-glandular ulcers
  • Increased VFA’s with increased grain
35
Medical Management of EGUS
  • Neutralizing agents
    • Antacids
  • Antisecretory agents
    • Histamine H2 receptor
      antagonists
    • Prostaglandin analog
    • Acid pump inhibitors
  • Others (antibiotics, neutriceuticals)
36
 
37
GASTROGARD® (Omeprazole)
  • New oral-paste formulation of omeprazole developed specifically for horses




  • Well-studied, effective, and safe therapy for EGUS
  • Approved for use in horses, March 1999
38
Ulcer Treatments Act at Different Sites
39
GastroGard® Allows
Healing/Improvement of Ulcers
40
GastroGard® Advantages
  • Profound gastric acid suppression
  • Prolonged duration of action
  • Once-daily dosing
  • Well studied in horses
  • No reported treatment-related
  •    health problems in equine trials
  • Prevents ulcer recurrence
  • Can maintain training program
  • Approved for use in horses (GASTROGARD®)
41
GastroGard®: Disadvantages
  • No IV formulation available in US
42
UlcerGardÔ
  • Prevention of ulcers
  • Non-perscription strength    of GastrogardÔ
  • Sold through veterinarians
43
Histamine H2 Receptor Antagonists
  • Zantac® (ranitidine), Tagamet® (cimetidine)
  • Competitive inhibition of the interaction of histamine with parietal cell
  • Dose-dependent inhibition of gastric acid secretion
44
Histamine H2 Receptor Antagonists:
Advantages & Disadvantages
  • Availability
  • Low cost (generic)
  • Zantac® has been shown to significantly inhibit gastric acid secretion in horses
  • Must be administered 3X daily
45
Antibiotic Treatment
  • Amoxicillin, metronidazole, clarithromycin,
    bismuth compounds, etc.
  • Primarily used in humans with
    Helicobacter pylori
  • H. pylori has been associated with
    the stomach of horses, but not EGUS
  • Antimicrobials may be used in horses
    with resistant EGUS
46
Recent Studies on Helicobacter spp.
  • Helicobacter specific DNA isolated from horse stomachs
  • 2 horses with squamous erosions
  • 1 horse with glandular erosions
  • ACVIM Forum-Dallas (May 2002)
47
Feed Supplements (Neutriceuticals)
  • NeighLox® (Kentucky Performance Products)
  • Antacid and Coating Agents:
    • Aluminum Phosphate, Calcium Carbonate
    • Dihydroxy-Aluminium
      Sodium Carbonate
  • Labeled for prevention
    of heartburn
  • No studies in horses
    to prove or disprove
  • Probably does not
    cause any harm
48
Feed Supplements (Neutriceuticals)
  • G.U.T (Uckele Health & Nutrition)
  • Gastric ulcer transnutrient for horses with ulcers
  • Ingredients
    • Gelatin
    • Lactobacillus acidophilus, L. lactis
  • Feed 15 grams (1 scoop) twice daily in horses with ulcers
  • No studies proving efficacy
49
Feed Supplements (Neutriceuticals)
  • TractGard (Foxden Equine)
  • Equine GI rehydrator, antacid, digestaid, and electrolyte salt
  • Ingredients (1 to 2 scoops daily)
    • Calcium carbonate, Sodium sequiscarbonate, KCl, MgSO4, distiller’s grain, yeast, and linseed meal
  • No studies on efficacy
50
 
51
Conclusions- General
  • EGUS is a major cause of illness
  • 60-93% of performance horses have EGUS
  • Impacts health, performance, economics
  • Occurs when aggressive factors overpower gastric defenses
52
Conclusions- General
  • Diagnosis requires endoscopy
  • Presumptive diagnosis made based on clinical signs following complete diagnostic evaluation
  • Treatment: management and medical interventions
53
Conclusions- Treatment
  • Zantac®-healing 3X daily treatment
  • Dietary supplements-not tested
  • GastroGard® (omeprazole)
    • Only FDA approved treatment
    • Provides potent, long-lasting gastric acid suppression in horses
      (once daily administration)
    • 92% to 99% improvement in ulcer scores in trials and a wide safety margin
  • UlcerGardÔ Prevention of Ulcers
54
Duodenal Ulcers/Stricture
  • Part of EGUS (more commonly in foals)
  • Similar pathogenesis
  • Similar clinical signs
    • Usually associated with bruxism, ptylism, and diarrhea (occurs most often in foals)
    • Delayed gastric emptying
  • Associated with esophageal
  •     ulcers
55
Duodenal Ulcers/Strictures
  • Diagnosis
    • Clinical signs
    • Duodenoscopy
    • Radiology
      •  gastric emptying with barium swallows (liquid meal=30 minutes)
    • Necropsy

56
Duodenal Ulcers/Strictures
  • Treatment
    • Omeprazole (4 mg/kg, PO, Q24h, 28 days)
    • Omeprazole (0.5 mg/kg, IV, Q24h)
    • Ranitidine (6.6 mg/kg, PO, Q8h)
  • Surgery-Gastrojejunostomy (foals only?)


57
Gastric Neoplasia
  • Uncommon in older horses
  • Squamous cell carcinoma, most common
    • Others: lymphosarcoma, adenosarcoma
  • Arises from squamous mucosa and metastasizes to the abdominal cavity and viscera and/or extends up the esophagus
  • Clinical signs:
    • Chronic weight loss
    • Anemia
    • Naso-gastric reflux
    • Colic
58
Gastric Neoplasia
  • Diagnosis
    • Clinical Signs
    • Endoscopy (definitive)
    • Abdominal ultrasound
    • Necropsy
  • Treatment: None
  • Prognosis: Grave
59
Gastric Impaction
  • Infrequent cause of Colic in horses
  • Dry feed material and decreased water intake
  • May occur during winter when dry hay is fed and water intake is lower
  • Diagnosed at surgery in horses with colic
  • Endoscopic examination
  • Treatment with dioctyl sodium succinate (DSS)
    • 5% solution via NG tube in 4 to 6 L fluid
  • Lavage at surgery, resolve in 24 – 48 hours